Megakaryocyte Contribution to Bone Marrow Fibrosis: many Arrows in the Quiver

Alessandro Malara1,2, Vittorio Abbonante1,2, Maria Zingariello3

  • 1Department of Molecular Medicine, University of Pavia, Pavia, Italy.

Insights

In Primary Myelofibrosis (PMF), abnormal megakaryocytes drive fibrosis by releasing inflammatory factors. This review explores how these cells and their secretions contribute to bone marrow fibrosis progression.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Primary Myelofibrosis (PMF) is characterized by bone marrow fibrosis.
  • Megakaryocyte abnormalities are implicated in PMF pathogenesis.
  • The precise mechanisms driving fibrosis in PMF remain incompletely understood.

Purpose of the Study:

  • To review the critical role of megakaryocytes in the development of myelofibrosis.
  • To elucidate the contribution of megakaryocyte-derived factors to bone marrow fibrosis.

Main Methods:

  • Literature review of studies on megakaryocytes and myelofibrosis.
  • Analysis of research on soluble factors, enzymes, and extracellular matrices secreted by megakaryocytes.
  • Synthesis of current understanding of PMF pathogenesis.

Main Results:

  • Megakaryocyte dysplasia and hyperplasia are key drivers of inflammatory cytokine release in PMF.
  • These cytokines activate stromal cells, promoting bone marrow fibrosis.
  • Altered megakaryocyte-derived soluble factors, enzymes, and extracellular matrices contribute significantly to fibrosis.

Conclusions:

  • Megakaryocytes play a central role in the progression of bone marrow fibrosis in PMF.
  • Understanding megakaryocyte-driven mechanisms is crucial for developing targeted therapies for PMF.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.2K
Binet's Contribution to Measures of Intelligence01:23

Binet's Contribution to Measures of Intelligence

Alfred Binet, along with his student Théophile Simon, was tasked by the French Ministry of Education in 1904 to create a method for identifying students who struggled to learn through conventional classroom instruction. This initiative aimed to address overcrowding by placing such students in specialized schools. Binet and Simon developed an intelligence test comprising 30 tasks, ranging from simple commands, like touching one's nose or ear, to more complex tasks, such as drawing...
1.7K
Wechsler's Contribution to Measures of Intelligence01:23

Wechsler's Contribution to Measures of Intelligence

David Wechsler, a psychologist who worked with World War I veterans, developed a significant IQ test in 1939 called the Wechsler-Bellevue Intelligence Scale. This test was innovative because it combined several subtests that measured both verbal and nonverbal skills, reflecting Wechsler's belief that intelligence is a global capacity involving purposeful action, rational thinking, and effective interaction with the environment. This test later evolved into the Wechsler Adult Intelligence...
2.1K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
874
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
541
Bone Structure01:55

Bone Structure

Within the skeletal system, the structure of a bone, or osseous tissue, can be exemplified in a long bone, like the femur, where there are two types of osseous tissue: cortical and cancellous.
51.7K